Metoclopramide Tablets Recalled for Presence of Foreign Tablets
Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP 10 mg due to the presence of foreign tablets or capsules in the product. The affected lot is distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is FDA Class II and involves a prescription drug with a manufacturing defect (foreign tablets/capsules in the product) that could result in serious patient harm. The presence of unidentified substances in a medication creates significant risk of adverse effects.
Plain-English summary
Teva Pharmaceuticals USA, Inc. is recalling Metoclopramide Tablets, USP 10 mg because foreign tablets or capsules have been found in the product. The recalled product is a prescription-only medication supplied in 100-count bottles.
The affected lot is Lot# 5420094 with an expiration date of 09/30/2027. Approximately 36,612 cartons have been distributed nationwide in the United States.
Consumers who have purchased this medication should not take it and should contact their pharmacy or healthcare provider. The presence of foreign tablets or capsules in the medication creates a safety risk, as patients may ingest unidentified substances instead of or in addition to their prescribed metoclopramide dose.
The recalled product
- Product
- METOCLOPRAMIDE (METOCLOPRAMIDE)
- Brand
- METOCLOPRAMIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Category
- Drug — Oral Tablet
- Affected units
- 36,612
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 5420094
- Exp 09/30/2027
UPCs (2)
- 0300932203013
- 0300932204010
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOCLOPRAMIDE
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-05-26
- HighTeva Recalls Metoclopramide Injection Due to Chemical Contamination
FDA (Drugs) · 2021-03-10
Same manufacturer · Teva Pharmaceuticals USA, Inc
See all →- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- ModerateClaravis isotretinoin 10 mg capsules recalled for out-of-specification impurity
FDA (Drugs) · 2026-04-29
- HighTeva isotretinoin 30 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Same hazard · foreign contamination
See all →- SevereCyclophosphamide Injection Recall: Stainless Steel Particulate Matter Found
FDA (Drugs) · 2026-08-12
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- HighNaropin Injection Recall Over Particulate Matter Contamination
FDA (Drugs) · 2026-07-29
- High3M Tegaderm CHG I.V. Dressing Recalled for Foreign Contamination
FDA (Devices) · 2024-10-16
Similar recalls
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- SevereTeva Recalls Metoclopramide Injection Due to Sterility Concerns
FDA (Drugs) · 2021-05-26
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- SevereMetoclopramide Injection Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-08-25
- HighTeva Recalls Metoclopramide Injection Due to Chemical Contamination
FDA (Drugs) · 2021-03-10